Address
Email address
Phone number
Website
https://www.molnlycke.comMölnlycke Health Care - A world leading MedTech companyMölnlycke Health Care is a world-leading MedTech company that specialises in sustainable solutions for wound care and surgical procedures.
Name
Mölnlycke Health Care OÜ
Registry code
10844153
VAT number
EE100743827
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.02.2002 (22)
Financial year
01.01-31.12
Capital
24 925.00 €
Activity
46901 - Non-specialised wholesale trade
5 592 028 €
360 525 €
6%
3 847 €
(estimate is approximate)
2 773 409 €
9
Submitted
No tax arrears
13%
11%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pille Loit 13.11.1961 (62) | - | - | Member of a higher management body, i.e. board member or supervisory board member |
| 2019 29.06.2020 | 2020 29.04.2021 | 2021 26.07.2022 | 2022 30.06.2023 | 2023 12.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 4 518 460 € | 4 598 958 € | 4 751 372 € | 5 668 248 € | 5 592 028 € |
| Net profit (loss) for the period | 295 576 € | 215 668 € | 112 941 € | 187 777 € | 360 525 € |
| Profit Margin | 7% | 5% | 2% | 3% | 6% |
| Current Assets | 2 314 523 € | 2 589 711 € | 2 842 687 € | 3 002 306 € | 3 155 893 € |
| Fixed Assets | 10 931 € | 7 594 € | 4 082 € | 18 168 € | 12 436 € |
| Total Assets | 2 325 454 € | 2 597 305 € | 2 846 769 € | 3 020 474 € | 3 168 329 € |
| Current Liabilities | 428 957 € | 485 140 € | 621 663 € | 607 590 € | 394 920 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 1 896 497 € | 2 112 165 € | 2 225 106 € | 2 412 884 € | 2 773 409 € |
| Employees | 13 | 10 | 10 | 9 | 9 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 804 196.64 € | 179 283.92 € | 42 975.98 € | 7 |
| 2023 Q4 | 1 428 086.75 € | 183 720.32 € | 42 296.01 € | 7 |
| 2023 Q3 | 1 262 214.13 € | 160 006.25 € | 45 190.76 € | 7 |
| 2023 Q2 | 1 674 980.91 € | 221 470.07 € | 58 517.6 € | 7 |
| 2023 Q1 | 1 782 685.88 € | 185 618.28 € | 39 152.72 € | 7 |
| 2022 Q4 | 1 622 504.8 € | 192 842.89 € | 36 798.05 € | 7 |
| 2022 Q3 | 1 291 402.97 € | 157 184.79 € | 35 871.84 € | 7 |
| 2022 Q2 | 1 690 239.02 € | 204 032.5 € | 53 940.09 € | 6 |
| 2022 Q1 | 1 686 754.66 € | 162 126.41 € | 34 279.9 € | 8 |
| 2021 Q4 | 1 235 838.99 € | 144 334.42 € | 32 852.03 € | 7 |
| 2021 Q3 | 1 237 438.61 € | 142 264.41 € | 34 102.51 € | 7 |
| 2021 Q2 | 1 294 041.41 € | 165 658.77 € | 52 988.97 € | 7 |
| 2021 Q1 | 1 201 345.03 € | 127 130.04 € | 29 659.29 € | 8 |
| 2020 Q4 | 1 474 882.7 € | 161 857.87 € | 33 350.49 € | 8 |
| 2020 Q3 | 1 164 634.22 € | 137 119.78 € | 32 245.62 € | 8 |
| 2020 Q2 | 1 078 361 € | 132 470.66 € | 31 018.88 € | 8 |
| 2020 Q1 | 1 389 147.26 € | 158 757.67 € | 43 670.88 € | 8 |
